|
Home >> Scientific Advisory Board |
| Andrew J. Dannenberg, M.D.
|
Andrew J. Dannenberg, M.D. is Director of Cancer Prevention at New York Presbyterian Hospital-Cornell. He is also the Henry R. Erle, M.D.-Roberts Family Professor of Medicine at Weill Medical College of Cornell University. Dr. Dannenberg received his medical degree from Washington University in St. Louis and served as a medical resident and gastroenterology fellow at The New York Hospital-Cornell Medical Center. He is a member of the American Society for Clinical Investigation, the American Association for Cancer Research, American Gastroenterological Association, American Association for the Study of Liver Diseases, and the International Society of Cancer Chemoprevention.
Among the honors and awards received by Dr. Dannenberg are the Upjohn Achievement Award for scientific research, the American Liver Foundation Scholar Award and the International Life Sciences Research Foundation Award. He is a member of Alpha Omega Alpha and Phi Beta Kappa. Dr. Dannenberg has authored more than 100 scientific articles, as well as edited several books and journals.
|
Steven M. Dubinett, M.D., Professor of Medicine and Pathology, Director, UCLA Lung Cancer Research Program, Chief of Division of Pulmonary and Critical Care Medicine, and Principal Investigator for the UCLA Lung Cancer SPORE, was recruited to UCLA from Massachusetts General Hospital in 1988 to direct the UCLA-Lung Cancer Research Laboratory. He has extensive experience in academic investigation, administration, mentorship and peer review. He has received federal peer-reviewed funding for lung cancer research for the past 17 years. Dr. Dubinett is nationally recognized for translational research in the immunobiology of lung cancer. Dr. Dubinett has served as a study section member and Ad Hoc reviewer for the NIH, the VA, the American Lung Association and the American Cancer Society. He has been a member of the NIH Experimental II (ET-2) study section and currently serves on the Cancer Immunopathology and Immunotherapy (CII) study section. He has co-chaired the NCI Lung Cancer SPORE review study section, served as a reviewer for Head and Neck Cancer SPOREs, the EDRN Biomarker Development Laboratory review committee and participated in numerous site visits for NCI program projects. He has been a member of the site visit teams for review of NCI Intramural Programs including reviews of the CCR Cancer and Cell Biology Branch as well as the Cancer Therapeutics Branch. Dr. Dubinett has received competitive awards for lung cancer research including the Cecile Lehman Mayer Research Award, the Helen Neufeld Award and the Career Investigator Award from the American Lung Association. He has served on numerous advisory committees and study sections and is currently a member of the NCI Translational Research Working Group (TRWG).
|
| Raymond N. DuBois, M.D., Ph.D.
|
Raymond N. DuBois is the B.F. Byrd Jr. Professor of Oncology, Professor of Medicine, Cancer Biology, and Cell/Developmental Biology at Vanderbilt-Ingram Cancer Center. Dr. DuBois currently serves on the Board of Scientific Advisors to the Director of the National Cancer Institute. He is also a member of the Board of Directors for the American Association for Cancer Research and Chairman of the Board of Directors for the Keystone Symposia on Molecular and Cellular Biology. He was selected as a member of the Scientific Advisory Board for the National Colorectal Cancer Research Alliance spearheaded by Katie Couric of the NBC Today Show. He is a well known cancer researcher who has numerous scholarly publications, editorial duties and research grants. He is past president of the Southern Society for Clinical Investigation and the Gastroenterology Research Group of the American Gastroenterological Association.
|
Dr. Mark R. Green, a renowned expert in lung cancer research and treatment, is a certified physician in Medical Oncology and Internal Medicine. Dr. Green is currently the Gilbreth Professor of Medicine Clinical Oncology at the Medical University of South Carolina (MUSC), and head of the Respiratory Disease Committee of the Cancer and Leukemia Group B (CALGB) Respiratory Disease Committee. He was a member of the Oncology Drugs Advisory Committee (ODAC). Between 1995 and 1999, Dr. Green served as Chair of the Subspecialty Board on Medical Oncology and as a member of the Board of Directors for the American Board of Internal Medicine. Dr. Green has also been Chief of Hematology and Oncology, and Director of the Hollings Cancer Center at MUSC. He was also the Tasch Professor of Oncology and Director of the Cancer Center at the University of California San Diego.
|
|
|
